On November 1st, Centers for Medicare and Medicaid Services (CMS)publishedits final rule for CY 2023 Hospital Outpatient Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment Systems and Quality Reporting Programs. Below are some major takeaways...
The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2022, released the calendar year 2023 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule. The Final Rule includes proposals to update payment rates, policies...
CMS decided not to finalize a provision that would have required PACE organizations to resolve grievances that could have an "imminent and significant" impact on the health or safety of the participant no later than 24 hours after receiving the grievance. Instead, the Final Rule notes that PACE...
On November 17, 2023, the U.S. Centers for Medicare & Medicaid Services (CMS or the Agency) published afinal rule(the Final Rule) requiring the disclosure of certain ownership, managerial, and other information from Medicare skilled nursing facilities (...
The Final Rule is effective on January 1, 2025, and, unless otherwise specified, applies to rebate calculations for applicable periods beginning on or after January 1, 2023, for Part B rebatable drugs and October 1, 2022, for Part D rebatable drugs. Medicare Part...
CMS has released thefinal rulefor price transparency in healthcare coverage, which aims to allow the public to have greater insight into healthcare costs in order to increase value. “This final rule is a historic step toward putting health care price information in the hands of ...
CMS has finalized policies to increase access to marketplace coverage and expand essential health benefits (EHBs) in the HHS 2025 Notice of Benefit and Payment Parameters final rule.
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or...
rates. For CY 2023, CMS did not finalize a payment rate of ASP minus 22.5 percent for drugs and biologicals acquired through the 340B program. Instead, CMS is applying the default rate, generally ASP plus 6 percent, to 340B-acquired drugs and biologicals in this final rule for CY 2023....
Donald H. Romano